Skip to main content
Poltreg S.A. logo

Poltreg S.A. — Investor Relations & Filings

Ticker · PTG ISIN · PLPLTRG00038 LEI · 259400XSAJTERJ42VZ86 WAR Professional, scientific and technical activities
Open in API
Filings indexed 359 across all filing types
Latest filing 2026-05-21 Governance Information
Country PL Poland
Listing WAR PTG

About Poltreg S.A.

https://poltreg.com/

Poltreg S.A. is a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases. The company specializes in treatments based on T-regulatory cells (Tregs), with an advanced pipeline of both polyclonal and engineered cell therapies. Its lead product, PTG-007, is an autologous Treg treatment being investigated for Type 1 Diabetes and Multiple Sclerosis. Poltreg is also advancing next-generation engineered therapies, including Chimeric Antigen Receptor T-regulatory cells (CAR-Tregs), for neuroinflammatory conditions such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS). The company operates its own state-of-the-art, cGMP-certified manufacturing facility to produce its advanced therapy medicinal products.

Recent filings

Filing Released Lang Actions
Sprawozdanie z działalności Rady Nadzorczej za rok 2025
Governance Information Classification · 85% confidence The document is titled “Sprawozdanie Rady Nadzorczej POLTREG S.A. z działalności w roku 2025” (Supervisory Board’s Report on Activities in 2025). It contains detailed sections on the composition and functions of the Supervisory Board, its committees (Audit Committee), independence criteria, assessment of internal controls, corporate governance practices, and an evaluation of the company’s situation and compliance. This is not a short announcement or link to another report, nor is it an audit certificate, financial statements, or management’s MD&A. Instead, it is a formal governance report detailing board structure, governance practices, oversight and evaluations. Therefore it best fits the Governance Information category (CGR).
2026-05-21 Polish
Raport biegłego dot. SoW
Audit Report / Information Classification · 95% confidence The document is a standalone audit report (“Raport niezależnego biegłego rewidenta”) on the completeness of the remuneration report, providing the auditor’s attestation and findings in accordance with relevant standards. It is not a full annual or interim financial statement but an independent auditor report, fitting the Audit Report / Information category.
2026-05-21 Polish
Sprawozdanie RN o wynagrodzeniach 2025
Remuneration Information Classification · 87% confidence The document is a standalone supervisory board report on executive and director remuneration for the 2025 financial year, containing detailed breakdowns of fixed, variable, and other compensation components for management and supervisory board members. This matches the definition of a Remuneration Information report (DET 14A).
2026-05-21 Polish
Projekty uchwał_17.06.2026
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a comprehensive set of “projekty uchwał” (draft resolutions) for the Ordinary General Meeting of PolTREG S.A. on June 17, 2026. It lists each agenda item, the proposed resolution text, statutory references, and explanatory notes (“Uzasadnienie”)—exactly the type of materials sent to shareholders to inform them of and solicit their votes on AGM resolutions. This is not the final AGM minutes or post-vote results (DVA), nor is it a regulatory announcement of a published report (RPA). Instead, it is the proxy/information statement accompanying the AGM notice. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI).
2026-05-21 Polish
Ogłoszenie WZA_17.06.2026
Regulatory Filings Classification · 85% confidence The document is a formal notice convening an Ordinary General Meeting of Shareholders (Walne Zgromadzenie) for June 17, 2026, including the agenda, statutory references, and procedural rules for participation and voting. It does not contain substantive financial statements or presentation slides, nor is it an earnings release or director change. It is a compliance announcement to shareholders about meeting logistics rather than the meeting materials themselves. Therefore, it best fits the Regulatory Filings (RNS) category as a general regulatory announcement.
2026-05-21 Polish
Polityka Wynagrodzeń Zarządu i Rady Nadzorczej 2026
Remuneration Information Classification · 92% confidence The document is the company’s formal “Polityka Wynagrodzeń” setting out fixed, variable, and incentive remuneration arrangements for management board and supervisory board members. This is a detailed executive compensation policy rather than a financial report or announcement, matching the Remuneration Information definition (DEF 14A).
2026-05-21 Polish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.